Evidence map›Paper›PMID 35465312›Full record

ArticleFrontiers in cell and developmental biology2022

Modeling Patient-Specific Muscular Dystrophy Phenotypes and Therapeutic Responses in Reprogrammed Myotubes Engineered on Micromolded Gelatin Hydrogels.

Florian Barthélémy, Jeffrey W Santoso, Laura Rabichow, Rongcheng Jin, Isaiah Little, Stanley F Nelson, Megan L McCain, M Carrie Miceli

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Florian BarthélémyDepartment of Microbiology Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, United States.
Jeffrey W SantosoLaboratory for Living Systems Engineering, Department of Biomedical Engineering, USC Viterbi School of Engineering, University of Southern California, Los Angeles, CA, United States.
Laura RabichowDepartment of Microbiology Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, United States.
Rongcheng JinLaboratory for Living Systems Engineering, Department of Biomedical Engineering, USC Viterbi School of Engineering, University of Southern California, Los Angeles, CA, United States.
Isaiah LittleDepartment of Microbiology Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, United States.
Stanley F NelsonCenter for Duchenne Muscular Dystrophy, University of California, Los Angeles, Los Angeles, CA, United States.
Megan L McCainLaboratory for Living Systems Engineering, Department of Biomedical Engineering, USC Viterbi School of Engineering, University of Southern California, Los Angeles, CA, United States.
M Carrie MiceliDepartment of Microbiology Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, United States.
University of California, Los Angeles · USLiving Systems (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

calpain 3DMDdystrophinexon skippinghydrogelsLGMD

Identifiers

PMID35465312
PMCPMC9020228
OpenAlexW4226047497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.